Oaktree Acquisition Corp. III Life Sciences (OACCU) Cash from Operations (2025 - 2026)
Oaktree Acquisition Corp. III Life Sciences' (OACCU) quarterly Cash from Operations came in at 158035.0 in Q1 2026, down 109.15% YoY from 1727366.21 in Q1 2025, and down 9.84% on a QoQ basis from 143876.0 in Q4 2025.
Oaktree Acquisition Corp. III Life Sciences (OACCU) Cash from Operations (2025 - 2026) Analysis & Trends
Oaktree Acquisition Corp. III Life Sciences (OACCU) has 2 years of Cash from Operations data on file, last reported at 158035.0 in Q1 2026.
- Quarterly Cash from Operations fell 109.15% year-over-year to 158035.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 504553.0 (changed N/A YoY) and the FY2025 annual result came in at 422079.0, down 370.61% from the prior year.
- Cash from Operations declined to 158035.0 in Q1 2026, from 143876.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 56518.0 in Q3 2025 to a low of 158035.0 in Q1 2026.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -97,260.00 |
| Jun 30, 2026 | -97,260.00 |
| Mar 31, 2026 | -158,035.00 |
| Mar 31, 2026 | -158,035.00 |
| Dec 31, 2025 | -143,876.00 |
| Dec 31, 2025 | -143,876.00 |
| Sep 30, 2025 | -56,518.00 |
| Sep 30, 2025 | -56,518.00 |
| Jun 30, 2025 | -146,124.00 |
| Jun 30, 2025 | -146,124.00 |
| Mar 31, 2025 | -75,561.00 |
| Mar 31, 2025 | -75,561.00 |